Background: PI4KA is a critical host factor for replication of hepatitis C virus in liver and a potential therapeutic target. Results: PI4KA inhibitors prevent the maintenance of PtdIns(4,5)P 2 pools during strong PLC activation. Conclusion: PI4KA plays a critical role in maintaining plasma membrane phosphoinositide pools. Significance: Safe pharmacological targeting of PI4KA is not feasible.

Hepatitis C virus (HCV) assembles many host cellular proteins into unique membranous replication structures as a prerequisite for viral replication, and PI4KIIIα is an essential component of these replication organelles. RNA interference of PI4KIIIα results in a breakdown of this replication complex and cessation of HCV replication in Huh-7 cells. PI4KIIIα is a lipid kinase that interacts with the HCV nonstructural 5A protein (NS5A) and enriches the HCV replication complex with its product, phosphoinositol 4-phosphate (PI4P). Elevated levels of PI4P at the endoplasmic reticulum have been linked to HCV infection in the liver of HCV infected patients. We investigated if small molecule inhibitors of PI4KIIIα could inhibit HCV replication in vitro. The synthesis and structure-activity relationships associated with the biological inhibition of PI4KIIIα and HCV replication are described. These efforts led directly to identification of quinazolinone 28 that displays high selectivity for PI4KIIIα and potently inhibits HCV replication in vitro.

Rapid clinical progress of hepatitis C virus (HCV) replication inhibitors, including these selecting for resistance in the NS5A region (NS5A inhibitors), promises to revolutionize HCV treatment. Herein, we describe our explorations of diverse spiropyrrolidine motifs in novel NS5A inhibitors and a proposed interaction model. We discovered that the 1,4-dioxa-7-azaspiro[4.4]nonane motif in inhibitor 41H (GSK2236805) supported high potency against genotypes 1a and 1b as well as in genotype 1b L31V and Y93H mutants. Consistent with this, 41H potently suppressed HCV RNA in the 20-day RNA reduction assay. Pharmacokinetic and safety data supported further progression of 41H to the clinic.

No abstract

As the conversion of MHP to the more toxic MTP was detected in the presence of collagenases, it is possible that collagenase-directed activation of prodrugs may be a promising approach for the development of more selective cytostatic drugs against malignant tumors with high collagenase activities.

Cholesteno Indoles, I. – Preparation of 1′H‐5α‐Cholest‐2‐eno[3,2‐b]indoles 1′H‐5α‐Cholest‐2‐eno[3,2‐b]indole (1a), the corresponding N‐methyl, N‐acetyl, and N‐formyl compounds 1b–d, as well as the respective methoxy derivatives 2b–5d have been synthesized as model compounds for intended CD investigations. Application of the Fischer indole synthesis afforded the compouds 1a–5a which were N‐methylated to 1b–5b, N‐acetylated to 1c–5c, and N‐formylated to 1d–5d.

No abstract

No abstract